JONATHAN LEI to Antineoplastic Agents
This is a "connection" page, showing publications JONATHAN LEI has written about Antineoplastic Agents.
Connection Strength
0.646
-
Proteogenomics drives therapeutic hypothesis generation for precision oncology. Br J Cancer. 2021 07; 125(1):1-3.
Score: 0.387
-
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer. Cancer Res. 2023 10 02; 83(19):3237-3251.
Score: 0.115
-
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins. Cancer Res Commun. 2023 08; 3(8):1551-1563.
Score: 0.114
-
Pan-cancer proteogenomics expands the landscape of therapeutic targets. Cell. 2024 Aug 08; 187(16):4389-4407.e15.
Score: 0.030